Blockade of eosinophil migration and airway hyperresponsiveness by cPLA2-inhibition

被引:53
作者
Myou, S
Sano, H
Fujimura, M
Zhu, XD
Kurashima, K
Kita, T
Nakao, S
Nonomura, A
Shioya, T
Kim, KP
Munoz, NM
Cho, WH
Leff, AR [1 ]
机构
[1] Univ Chicago, Dept Med, Pulm & Crit Care Med Sect, Chicago, IL 60637 USA
[2] Kanazawa Univ Hosp, Pathol Sect, Kanazawa, Ishikawa 9208641, Japan
[3] Univ Illinois, Dept Chem, Chicago, IL 60680 USA
[4] Kanazawa Univ, Sch Med, Dept Internal Med 3, Kanazawa, Ishikawa 9208641, Japan
[5] Univ Chicago, Dept Neurobiol Pharmacol & Physiol, Chicago, IL 60637 USA
[6] Univ Chicago, Comm Clin Pharmacol & Cell Physiol, Chicago, IL 60637 USA
关键词
D O I
10.1038/84244
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We examined the role of a cytosolic phospholipase A(2) (cPLA(2)) in antigen-induced eosinophil infiltration of airways and in airway hyperresponsiveness to methacholine. Inhibition of cPLA(2), or blockade of the platelet-activating faster (PAF) receptor, blocked antigen-induced airway hyperresponsiveness and suppressed eosinophil infiltration. Neither cyclooxygenase nor 5-lipoxygenase inhibition had either effect. We show here that, in antigen-sensitized guinea pigs, cPLA(2) inhibition prevents both eosinophilic infiltration and subsequent airway hyperresponsiveness after antigen challenge. We also show that this effect is mediated by first-step hydrolysis of membrane phospholipid into lysophospholipid rather than by prostanoid or leukotriene metabolites of arachidonate.
引用
收藏
页码:145 / 149
页数:5
相关论文
共 45 条
[1]   ANTIGEN-INDUCED BRONCHIAL ANAPHYLAXIS IN ACTIVELY SENSITIZED GUINEA-PIGS - THE EFFECT OF BOOSTER INJECTION AND CYCLOPHOSPHAMIDE TREATMENT [J].
ANDERSSON, P .
INTERNATIONAL ARCHIVES OF ALLERGY AND APPLIED IMMUNOLOGY, 1981, 64 (03) :249-258
[2]   EFFECT OF YM264 ON THE AIRWAY HYPERRESPONSIVENESS AND THE LATE ASTHMATIC RESPONSE IN A GUINEA-PIG MODEL OF ASTHMA [J].
ARIMA, M ;
YUKAWA, T ;
MAKINO, S .
CHEST, 1995, 108 (02) :529-534
[3]  
ASHIDA Y, 1983, PROSTAGLANDINS, V26, P955, DOI 10.1016/0090-6980(83)90157-0
[4]   NEW CONCEPTS IN THE PATHOGENESIS OF BRONCHIAL HYPERRESPONSIVENESS AND ASTHMA [J].
BARNES, PJ .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1989, 83 (06) :1013-1026
[5]   EOSINOPHILIC INFLAMMATION IN ASTHMA [J].
BOUSQUET, J ;
CHANEZ, P ;
LACOSTE, JY ;
BARNEON, G ;
GHAVANIAN, N ;
ENANDER, I ;
VENGE, P ;
AHLSTEDT, S ;
SIMONYLAFONTAINE, J ;
GODARD, P ;
MICHEL, FB .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (15) :1033-1039
[6]   Antigen-induced generation of lyso-phospholipids in human airways [J].
Chilton, FH ;
Averill, FJ ;
Hubbard, WC ;
Fonteh, AN ;
Triggiani, M ;
Liu, MC .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (05) :2235-2245
[7]  
CUSS FM, 1986, LANCET, V2, P189
[8]   Pretreatment with antibody to eosinophil major basic protein prevents hyperresponsiveness by protecting neuronal M-2 muscarinic receptors in antigen-challenged guinea pigs [J].
Evans, CM ;
Fryer, AD ;
Jacoby, DB ;
Gleich, GJ ;
Costello, RW .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (09) :2254-2262
[9]   Effects of a potent platelet-activating factor antagonist, SR27417A, on allergen-induced asthmatic responses [J].
Evans, DJ ;
Barnes, PJ ;
Cluzel, M ;
OConnor, BJ .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1997, 156 (01) :11-16
[10]   EFFECT OF CHRONIC 5-LIPOXYGENASE INHIBITION ON AIRWAY HYPERRESPONSIVENESS IN ASTHMATIC SUBJECTS [J].
FISCHER, AR ;
MCFADDEN, CA ;
FRANTZ, R ;
AWNI, WM ;
COHN, J ;
DRAZEN, JM ;
ISRAEL, E .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1995, 152 (04) :1203-1207